Publications

All our publications

*Listed are the articles found in the PubMed database.

Publications by “Wolfgang Alexander Link Grosslinger”

DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study.

Faleiro, I, Roberto, VP, Demirkol Canli, S, Fraunhoffer, NA, Iovanna, J, Gure, AO, Link, W , Castelo-Branco, P.

One-minute and green synthesis of magnetic iron oxide nanoparticles assisted by design of experiments and high energy ultrasound: Application to biosensing and immunoprecipitation.

Pérez-Beltrán, CH, García-Guzmán, JJ, Ferreira, B, Estévez-Hernández, O, López-Iglesias, D, Cubillana-Aguilera, L, Link, W , Stănică, N, Rosa da Costa, AM, Palacios-Santander, JM.

TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.

Hill, R, Madureira, PA, Ferreira, B, Baptista, I, Machado, S, Colaço, L, Dos Santos, M, Liu, N, Dopazo, A, Ugurel, S, Adrienn, A, Kiss-Toth, E, Isbilen, M, Gure, AO, Link, W .

Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling.

Cautain, B, Castillo, F, Musso, L, Ferreira, BI, de Pedro, N, Rodriguez Quesada, L, Machado, S, Vicente, F, Dallavalle, S, Link, W .

Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition.

Tarrado-Castellarnau, M, Cortés, R, Zanuy, M, Tarragó-Celada, J, Polat, IH, Hill, R, Fan, TW, Link, W , Cascante, M.

Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.

Mori, M, Vignaroli, G, Cau, Y, Dinić, J, Hill, R, Rossi, M, Colecchia, D, Pešić, M, Link, W , Chiariello, M, Ottmann, C, Botta, M.

A novel cyclometallated Pt(II)-ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation.

Cortés, R, Tarrado-Castellarnau, M, Talancón, D, López, C, Link, W , Ruiz, D, Centelles, JJ, Quirante, J, Cascante, M.

High-content screening of natural products reveals novel nuclear export inhibitors.

Cautain, B, de Pedro, N, Murillo Garzón, V, Muñoz de Escalona, M, González Menéndez, V, Tormo, JR, Martin, J, El Aouad, N, Reyes, F, Asensio, F, Genilloud, O, Vicente, F, Link, W .

Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation.

Zanella, F, Dos Santos, NR, Link, W .

Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.

Granda, TG, Cebrián, D, Martínez, S, Anguita, PV, López, EC, Link, W , Merino, T, Pastor, J, Serelde, BG, Peregrina, S, Palacios, I, Albarran, MI, Cebriá, A, Lorenzo, M, Alonso, P, Fominaya, J, López, AR, Bischoff, JR.

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

Martínez González, S, Hernández, AI, Varela, C, Lorenzo, M, Ramos-Lima, F, Cendón, E, Cebrián, D, Aguirre, E, Gomez-Casero, E, Albarrán, MI, Alfonso, P, García-Serelde, B, Mateos, G, Oyarzabal, J, Rabal, O, Mulero, F, Gonzalez-Granda, T, Link, W , Fominaya, J, Barbacid, M, Bischoff, JR, Pizcueta, P, Blanco-Aparicio, C, Pastor, J.

Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

Martínez González, S, Hernández, AI, Varela, C, Rodríguez-Arístegui, S, Lorenzo, M, Rodríguez, A, Rivero, V, Martín, JI, Saluste, CG, Ramos-Lima, F, Cendón, E, Cebrián, D, Aguirre, E, Gomez-Casero, E, Albarrán, M, Alfonso, P, García-Serelde, B, Oyarzabal, J, Rabal, O, Mulero, F, Gonzalez-Granda, T, Link, W , Fominaya, J, Barbacid, M, Bischoff, JR, Pizcueta, P, Pastor, J.

Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.

Martínez González, S, Hernández, AI, Varela, C, Rodríguez-Arístegui, S, Alvarez, RM, García, AB, Lorenzo, M, Rivero, V, Oyarzabal, J, Rabal, O, Bischoff, JR, Albarrán, M, Cebriá, A, Alfonso, P, Link, W , Fominaya, J, Pastor, J.

An integrated one-step system to extract, analyze and annotate all relevant information from image-based cell screening of chemical libraries.

Rabal, O, Link, W , Serelde, BG, Bischoff, JR, Oyarzabal, J.

Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases.

Link, W , Oyarzabal, J, Serelde, BG, Albarran, MI, Rabal, O, Cebriá, A, Alfonso, P, Fominaya, J, Renner, O, Peregrina, S, Soilán, D, Ceballos, PA, Hernández, AI, Lorenzo, M, Pevarello, P, Granda, TG, Kurz, G, Carnero, A, Bischoff, JR.

An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays.

Zanella, F, Rosado, A, Blanco, F, Henderson, BR, Carnero, A, Link, W .

Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt.

Link, W , Rosado, A, Fominaya, J, Thomas, JE, Carnero, A.

Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland.

Link, WA , Ledo, F, Torres, B, Palczewska, M, Madsen, TM, Savignac, M, Albar, JP, Mellström, B, Naranjo, JR.

Somatodendritic expression of an immediate early gene is regulated by synaptic activity.

Link, W , Konietzko, U, Kauselmann, G, Krug, M, Schwanke, B, Frey, U, Kuhl, D.

C/ Arturo Duperier 4 | 28029 Madrid (España) | Teléfono +(34) 91 585 4400 | Código DIR3: E02764003